Timmers H J L M, van Ginneken E M, Wesseling P, Sweep C G J, Hermus A R M M
Department of Endocrinology, Radboud University, Nijmegen Medical Center, PO box 9101, 6500 HB Nijmegen, The Netherlands.
J Endocrinol Invest. 2006 Nov;29(10):934-9. doi: 10.1007/BF03349200.
A 41-yr-old female was referred for signs and symptoms of Cushing's syndrome. Cortisol was not suppressed by 1 mg dexamethasone (0.41 micromol/l). Midnight cortisol and ACTH were 0.44 micromol/l and 18 pmol/l, respectively. Urinary cortisol excretion was 250 nmol/24 h (normal between 30 and 150 nmol/24 h). A magnetic resonance imaging (MRI) revealed a pituitary lesion of 7 mm. ACTH and cortisol levels were unaltered by administration of human CRH and high-dose dexamethasone. Inferior sinus petrosus sampling showed CRH-stimulated ACTH levels of 128.4 (left sinus) vs a peripheral level of 19.2 pmol/l, indicating Cushing's disease. After 4 months of pre-treatment with metyrapone and dexamethasone, endoscopic transsphenoidal resection of an ACTH-positive pituitary adenoma was performed. ACTH levels decreased to 2.6 pmol/l and fasting cortisol was 0.35 micromol/l. Despite clinical regression of Cushing's syndrome and normalization of urinary cortisol, cortisol was not suppressed by 1 mg dexamethasone (0.30 micromol/l). Ten months post-operatively, signs and symptoms of Cushing's syndrome reoccurred. A high dose dexamethasone test according to Liddle resulted in undetectable ACTH, but no suppression of cortisol levels, pointing towards adrenal-dependent Cushing's syndrome. Computed tomography (CT)-scanning showed a left-sided adrenal macronodule. Laparoscopic left adrenalectomy revealed a cortical macronodule (3.5 cm) surrounded by micronodular hyperplasia. Fasting cortisol had decreased to 0.02 micromol/l. Glucocorticoid suppletion was started and tapered over 12 months. Symptoms and signs of hypercortisolism gradually disappeared. This case illustrates, that longstanding ACTH stimulation by a pituitary adenoma can induce unilateral macronodular adrenal hyperplasia with autonomous cortisol production.
一名41岁女性因库欣综合征的症状和体征前来就诊。1毫克地塞米松(0.41微摩尔/升)未能抑制皮质醇。午夜皮质醇和促肾上腺皮质激素(ACTH)分别为0.44微摩尔/升和18皮摩尔/升。尿皮质醇排泄量为250纳摩尔/24小时(正常范围为30至150纳摩尔/24小时)。磁共振成像(MRI)显示垂体有一个7毫米的病变。给予人促肾上腺皮质激素释放激素(CRH)和高剂量地塞米松后,ACTH和皮质醇水平未改变。岩下窦采血显示,CRH刺激后左侧窦ACTH水平为128.4,外周水平为19.2皮摩尔/升,提示库欣病。在接受美替拉酮和地塞米松预处理4个月后,进行了经鼻内镜垂体ACTH阳性腺瘤切除术。ACTH水平降至2.6皮摩尔/升,空腹皮质醇为0.35微摩尔/升。尽管库欣综合征的临床症状消退且尿皮质醇恢复正常,但1毫克地塞米松(0.30微摩尔/升)仍未能抑制皮质醇。术后10个月,库欣综合征的症状和体征再次出现。根据利德尔法进行的高剂量地塞米松试验显示ACTH检测不到,但皮质醇水平未被抑制,提示为肾上腺依赖性库欣综合征。计算机断层扫描(CT)显示左侧肾上腺有一个大结节。腹腔镜下左侧肾上腺切除术显示一个皮质大结节(3.5厘米),周围有小结节性增生。空腹皮质醇已降至0.02微摩尔/升。开始给予糖皮质激素补充,并在12个月内逐渐减量。高皮质醇血症的症状和体征逐渐消失。该病例表明,垂体腺瘤长期刺激ACTH可导致单侧大结节性肾上腺增生并自主分泌皮质醇。